Polish case report about patient with premature ejaculation after discontinuation

[future-recovery]

Thanks, but are you sure that they blamed HIV and not his anxiety due to HIV? If they blamed his anxiety due to HIV, then it would mean that they thought that it was a relapse. What is the conclusion of the case study?

[PSSDisintheliver]

Yes im'positive,They didn't blame HIV,thats the conclusion i've drawn. The final conclusion is they are very surprised and its atypical for SSRI to have these symptoms after discontinuation.

[future-recovery]

Thank you.
So if his symptoms improved by taking an SSRI again, it could be a similiar case as this case report (though we can't really compare the Polish case report because the SSRI was not discontinued again):
https://www.researchgate.net/publicatio ... Withdrawal

[future-recovery]

But I still doubt whether you have described it correctly.
I have translated the conclusion via google translate and it rather sounds that they think that it was caused by anxiety due to HIV:

Google translate:

Is it really described the clinical situation should be qualified as a team the end of treatment with SSRI?
It seems that there is no basis for such classification worsening
ing. Symptoms appeared unusually for the team completion
SSRI therapy - not soon (10 days) after the withdrawal of the drug,
but a few weeks later. Symptoms observed several (symptoms
Somatic general sense break, depressed mood
and drive, concern about health, worse quality of sleep) or several
(Premature ejaculation) weeks after discontinuation of the drug in opisy-
of an important patient should be treated as a drug-relapse disorders
Outgoing. Before starting treatment, the severity of anxiety and ailments
COMPONENTS somatyzacyjnych and their variability were large, like
It happened after the end of treatment with fluoxetine. Appearance
symptoms that did not exist in the past, of course
is nothing exceptional, their relationship with the sexual sphere can
result from the patient's anticipated HIV infection, con-
centration on sexual performance.
Applied patient Fluoxetine is a drug with the least
the risk of symptoms of the end of SSRI therapy,
sometimes also recommended in the short term at weaning in-
of drugs in this group (11). Fluoxetine, as indicated in wstę-
pie, has an extremely long half-life - 1-3 days while at the same
norazowej dose when taking longer to 6 days, with
Because the concentration of modulated metabolism. Norfluokse-
Tyna which is the active metabolite of fluoxetine too long
It remains active - even 16 days (12,13).
To conclude the treatment, slowly reduce the dose, particularly
not in patients in whom the start of treatment occurred
symptoms worse tolerability (14). If on the other hand, we are dealing
pressure of the symptoms of post-treatment can be resumed
the previously used substances and slowly, carefully her response
place (15).